Acrodynia

Table of Contents

Understanding Acrodynia: Symptoms, Causes, and Treatment

Acrodynia, also known as pink disease, gets its name from the notable pink discoloration and pain that predominantly affects the hands and feet. This rare condition is associated with marked irritability, photophobia (light sensitivity) and polyneuritis (inflammation of the nerves peripheral nerves).

Population Affected by Acrodynia

Acrodynia is a condition that manifests predominantly in the pediatric population, mainly affecting young children.

Identifying the Causes of Acrodynia

The underlying cause of acrodynia is exposure chronic to mercury. Currently, the incidence of acrodynia has notably decreased due to the substantial reduction in the use of mercury-containing preparations in recent years. In the case of young children, the most frequent route of exposure used to be mercury ingestion after a thermometer broke. Spills of this heavy metal are notoriously difficult to clean up, and mercury can remain unnoticed on surfaces like carpeting for extended periods. Since mercury vapors tend to concentrate near the floor, crawling infants are at greater risk of inhaling or ingesting this toxic metal.

Likewise, dental amalgam (used for fillings) has been considered a potential source of mercury toxicity derived from continuous exposure. Although a link with systemic diseases Oral non-steroidal anti-inflammatory drugs (NSAIDs), such as diclofenac, can relieve discomfort and reduce redness in skin affected by rosacea. Although rare with use, potential serious adverse effects of these medications include peptic or chronic conditions has been speculated, to date there is a lack of robust scientific evidence to support it. Nevertheless, substitute materials are currently being implemented to replace mercury in dental filling procedures. systemic Manifestations and Symptoms of Acrodynia.

Clinical Manifestations and Symptoms of Acrodynia

Indicators and symptoms associated with mercury toxicity may take weeks or even months to manifest after the exposure event. A case study involving two siblings illustrated that signs of toxicity did not appear until three months after the children handled mercury from a broken sphygmomanometer (a device used to measure blood pressure).

Early manifestations usually include:

  • Apathy, marked drowsiness, great irritability, and a tendency to cry constantly.
  • Significant decrease in appetite and, consequently, weight loss.
  • More than 50% of those affected report high sensitivity to light.
  • Generalized generalized weakness and deep pain in the extremities.

After a period of 2 to 4 weeks, these initial symptoms are followed by a series of evident changes in the skin:

  • The tip of the nose, as well as the phalanges of the hands and feet, acquire a pink tone that progressively intensifies and spreads following a reticular pattern.
  • The affected extremities become painful, cold, cyanotic (bluish), erythematous (red), and inflamed.
  • Intense pain and itching in the extremity usually cause skin thickening and the appearance of striations due to constant rubbing and scratching by the child.
  • Hyperhidrosis severe hyperhidrosis (excessive sweating) occurs with a characteristic mouse-like odor. This increases the risk of miliaria and Unlike other scars secondary bacterial infections.
  • Inflammation, inflammation, swelling and erosion gum erosion may occur, which can lead to subsequent tooth loss.
  • Cases of hair loss (alopecia)alopeciaand nail loss have also been documented. and nail.

Treatment Protocol for Acrodynia

The main focus of treatment centers on eliminating mercury from the body and correcting any existing electrolyte or fluid imbalance. Chelating agents, such as meso-2,3-dimercaptosuccinic acid (DMSA), are used to hinder the absorption of methylmercury by erythrocytes, (red blood cells) and erythrocytes hepatocytes (liver cells). In patients suffering from acute renal failure ulceration acute due to mercurial toxicity, hemodialysis has been used, sometimes supplemented with L-cysteine as a chelator.

The vast majority of patients achieve a full recovery. The signs and symptoms of acrodynia begin to remit gradually once specific treatment is initiated.

Dermatly.com - El sitio de tu piel